TB-500

Thymosin beta 4 (Tβ4) is an actin-sequestering peptide widely recognized for its central role in tissue repair, cellular regeneration, and cytoprotection, with extensive research demonstrating its broad therapeutic potential across multiple organ systems. A key regulator of cytoskeletal dynamics, Tβ4 binds to G-actin, enabling precise control of cell structure, migration, and motility—processes essential for directing regenerative cells to sites of injury. Through the promotion of angiogenesis, Tβ4 supports the formation of new blood vessels, thereby improving oxygen and nutrient delivery required for effective wound healing. Its regenerative actions extend across skin, corneal tissue, cardiac muscle, and other organs, where it has been shown to accelerate repair, enhance recovery from ischemic injury, and reduce fibrotic scar formation. Tβ4 also exhibits potent anti-inflammatory and anti-apoptotic properties by modulating inflammatory cytokine activity and protecting cells from programmed cell death, which collectively help preserve tissue integrity and limit secondary damage following injury. These multifunctional effects have led to growing interest in Tβ4 as a candidate for treating chronic wounds such as diabetic ulcers, inflammatory conditions including inflammatory bowel disease, and organ protection applications involving cardiac, hepatic, and ocular injury. Its combined influence on cellular migration, angiogenesis, inflammation, and survival positions Tβ4 as a key peptide in the study of regenerative medicine and tissue restoration.